Home > Balance Sheet > NATH BIOGENES (INDIA)

NATH BIOGENES (INDIA)
Total Current Liabilities

    Back to Balance Sheet
NATH BIOGENES (INDIA) is part of below Screeners ↓
Top Undervalued Small Cap Stocks
AD     Remove this Ad

NATH BIOGENES (INDIA) Last 5 Year Total Current Liabilities History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2013
Total Current Liabilities ₹365 Cr₹262 Cr₹216 Cr₹194 Cr₹98 Cr

What is the latest Total Current Liabilities ratio of NATH BIOGENES (INDIA) ?

The latest Total Current Liabilities ratio of NATH BIOGENES (INDIA) is ₹365 Cr based on Mar2025 Consolidated results.
Year Total Current Liabilities
Mar2025₹365 Cr
Mar2024₹262 Cr
Mar2023₹216 Cr
Mar2022₹194 Cr
Mar2013₹98 Cr

How is Total Current Liabilities of NATH BIOGENES (INDIA) Trending?

Years Total Current Liabilities % Change
Mar2025 ₹365 Cr
39.19
Mar2024 ₹262 Cr
21.26
Mar2023 ₹216 Cr
11.40
Mar2022 ₹194 Cr
98.02
Mar2013 ₹98 Cr -

Compare Total Current Liabilities of peers of NATH BIOGENES (INDIA)

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
NATH BIOGENES (INDIA) ₹246.3 Cr -7.4% -13.6% -9.4% Stock Analytics
BOMBAY BURMAH TRADING CORPORATION ₹9,596.4 Cr -8.5% -22.1% -20.6% Stock Analytics
KAVERI SEED COMPANY ₹4,071.2 Cr -2.7% -1.2% -36.3% Stock Analytics
VENKYS (INDIA) ₹1,710.9 Cr -6.9% -11.2% -24.9% Stock Analytics
BOMBAY SUPER HYBRID SEEDS ₹707.0 Cr -14.1% -25.9% -41.4% Stock Analytics
INDO US BIOTECH ₹200.7 Cr -4.8% -30.6% -34.8% Stock Analytics


NATH BIOGENES (INDIA) Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
NATH BIOGENES (INDIA)

-7.4%

-13.6%

-9.4%

SENSEX

-0.8%

-11.7%

-3.6%


You may also like the below Video Courses